A recent study in this same study cohort demonstrated that plasma tau concentrations were associated with cognitive deficits in children with CM but not SMA [44], suggesting that long-term neurocognitive impairment may be occurring by a different mechanism in children with CM than SMA. The gene discussed is MAPT; the disease is cutaneous mastocytosis.